- Home
- DRMA vs EZGO Comparison
DRMA vs EZGO Comparison
Compare DRMA & EZGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- EZGO
- Stock Information
- Founded
- DRMA 2014
- EZGO 2014
- Country
- DRMA United States
- EZGO China
- Employees
- DRMA N/A
- EZGO N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- EZGO Motor Vehicles
- Sector
- DRMA Health Care
- EZGO Consumer Discretionary
- Exchange
- DRMA Nasdaq
- EZGO Nasdaq
- Market Cap
- DRMA 2.1M
- EZGO 1.8M
- IPO Year
- DRMA 2021
- EZGO 2021
- Fundamental
- Price
- DRMA $3.11
- EZGO $0.15
- Analyst Decision
- DRMA Strong Buy
- EZGO
- Analyst Count
- DRMA 1
- EZGO 0
- Target Price
- DRMA $10.00
- EZGO N/A
- AVG Volume (30 Days)
- DRMA 51.3K
- EZGO 24.0M
- Earning Date
- DRMA 11-07-2025
- EZGO 07-01-2025
- Dividend Yield
- DRMA N/A
- EZGO N/A
- EPS Growth
- DRMA N/A
- EZGO N/A
- EPS
- DRMA N/A
- EZGO N/A
- Revenue
- DRMA N/A
- EZGO $20,895,830.00
- Revenue This Year
- DRMA N/A
- EZGO N/A
- Revenue Next Year
- DRMA N/A
- EZGO N/A
- P/E Ratio
- DRMA N/A
- EZGO N/A
- Revenue Growth
- DRMA N/A
- EZGO 18.98
- 52 Week Low
- DRMA $2.90
- EZGO $0.11
- 52 Week High
- DRMA $23.70
- EZGO $1.18
- Technical
- Relative Strength Index (RSI)
- DRMA 32.99
- EZGO 46.88
- Support Level
- DRMA $2.95
- EZGO $0.14
- Resistance Level
- DRMA $3.32
- EZGO $0.29
- Average True Range (ATR)
- DRMA 0.24
- EZGO 0.03
- MACD
- DRMA -0.01
- EZGO 0.00
- Stochastic Oscillator
- DRMA 16.42
- EZGO 13.73
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.